Studi e Ricerche Shedir Pharma Group

Document Number Contract Type Document Date Sender Object Note
(file - 650.33 kb) Monographic Study 30/04/2024 KT&Partners Shedir Pharma Group S.p.A.
(file - 534.39 kb) Monographic Study 24/10/2023 KT&Partners Shedir Pharma Group S.p.A.
(file - 506.96 kb) Monographic Study 11/04/2023 KT&Partners Shedir Pharma Group S.p.A.
(file - 555.88 kb) Monographic Study 28/10/2022 KT&Partners Shedir Pharma Group S.p.A.
(file - 1.18 mb) Monographic Study 03/08/2022 Banca Akros Shedir Pharma Group S.p.A.
(file - 1.16 mb) Monographic Study 10/06/2022 Banca Akros Shedir Pharma Group S.p.A.
(file - 1.84 mb) Monographic Study 29/04/2022 Banca Akros Shedir Pharma Group S.p.A.
(file - 1.23 mb) Monographic Study 30/03/2022 Banca Akros Shedir Pharma Group S.p.A.
(file - 1.14 mb) Monographic Study 29/11/2021 Banca Akros Shedir Pharma Group S.p.A.
(file - 915.97 kb) Monographic Study 30/09/2021 Banca Akros Shedir Pharma Group S.p.A.
(file - 749.54 kb) Monographic Study 22/04/2021 Banca Akros Shedir Pharma Group S.p.A.
(file - 808.37 kb) Monographic Study 30/03/2021 Banca Akros Shedir Pharma Group S.p.A.
(file - 855.66 kb) Monographic Study 29/03/2021 Banca Akros Shedir Pharma Group S.p.A.
(file - 539.48 kb) Monographic Study 15/12/2020 Banca Akros Shedir Pharma Group S.p.A.
(file - 2.09 mb) Monographic Study 10/11/2020 Banca Akros Shedir Pharma Group S.p.A.
(file - 348.33 kb) Monographic Study 22/10/2020 KT&Partners Shedir Pharma Group S.p.A.
(file - 698.35 kb) Monographic Study 30/09/2020 Banca Akros Shedir Pharma Group S.p.A.
(file - 630.36 kb) Monographic Study 25/09/2020 Banca Akros Shedir Pharma Group S.p.A.
(file - 532.96 kb) Monographic Study 07/08/2020 Banca Akros Shedir Pharma Group S.p.A.
(file - 492.45 kb) Monographic Study 29/05/2020 Banca Akros Shedir Pharma Group S.p.A.

Tutti gli Studi e le Ricerche Shedir Pharma Group


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.